製品名:2-[(5-{4-[2-(1,2-benzoxazol-3-yl)acetyl]piperazin-1-yl}-1,3,4-thiadiazol-2-yl)sulfanyl]-N-phenylacetamide

IUPAC Name:2-[(5-{4-[2-(1,2-benzoxazol-3-yl)acetyl]piperazin-1-yl}-1,3,4-thiadiazol-2-yl)sulfanyl]-N-phenylacetamide

CAS番号:1105225-53-3
分子式:C23H22N6O3S2
純度:95%+
カタログ番号:CM835552
分子量:494.59

包装単位 有効在庫 価格(USD) 数量

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1105225-53-3
分子式:C23H22N6O3S2
融点:-
SMILESコード:O=C(CSC1=NN=C(S1)N1CCN(CC1)C(=O)CC1=NOC2=C1C=CC=C2)NC1=CC=CC=C1
密度:
カタログ番号:CM835552
分子量:494.59
沸点:
MDL番号:
保管方法:

Category Infos

Piperazines
Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.
Benzoisoxazoles
1,2-Benzoisoxazole is an aromatic organic compound with the molecular formula C7H5NO containing a benzene-fused isoxazole ring structure. The compound itself has no general application; however, functionalized benzoxazoles and benzoisoxazoles have a variety of uses, including therapeutic drugs such as some antipsychotics (including risperidone, paliperidone, cape ketone and iloperidone) and the anticonvulsant azolamide.
Thiadiazoles
Thiadiazoles are a subfamily of azoles. Structurally, they are five-membered heterocyclic compounds containing two nitrogen atoms and one sulfur atom, and two double bonds, forming an aromatic ring. Depending on the relative positions of the heteroatoms, there are four possible structures; these forms do not interconvert and are therefore structural isomers rather than tautomers. These compounds themselves are rarely synthesized and have no particular utility, however, compounds that use them as structural motifs are fairly common in pharmacology.